120 related articles for article (PubMed ID: 31805655)
1. Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC
Piyasiridej S; Townamchai N; Udomkarnjananun S; Vadcharavivad S; Pongpirul K; Wattanatorn S; Sirichindakul B; Avihingsanon Y; Tungsanga K; Eiam-Ong S; Praditpornsilpa K
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31805655
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
3. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
[TBL] [Abstract][Full Text] [Related]
4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Kamar N; Marquet P; Gandia P; Muscari F; Lavayssière L; Esposito L; Guitard J; Canivet C; Peron JM; Alric L; Suc B; Saint-Marcoux F; Rostaing L
Ther Drug Monit; 2009 Aug; 31(4):451-6. PubMed ID: 19531983
[TBL] [Abstract][Full Text] [Related]
6. A Study of the Pharmacokinetic Comparison between the Generic and Original Form of Mycophenolate Mofetil Among Thai Renal Transplant Patients.
Larpparisuth N; Pinpaiboon S; Ratchawang N; Promraj R; Skulratanasak P; Vongwiwatana A; Premasathian N
Transplant Proc; 2019 Oct; 51(8):2629-2632. PubMed ID: 31471014
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
[TBL] [Abstract][Full Text] [Related]
8. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients.
Zhang J; Sun Z; Zhu Z; Yang J; Kang J; Feng G; Zhou L; Zuo L; Luo Y; Zhang X
Front Pharmacol; 2018; 9():908. PubMed ID: 30150939
[TBL] [Abstract][Full Text] [Related]
10. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients.
Armstrong VW; Tenderich G; Shipkova M; Parsa A; Koerfer R; Schröder H; Oellerich M
Ther Drug Monit; 2005 Jun; 27(3):315-21. PubMed ID: 15905802
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182
[TBL] [Abstract][Full Text] [Related]
13. Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients.
Xiang H; Zhou H; Zhang J; Sun Y; Wang Y; Han Y; Cai J
Front Pharmacol; 2021; 12():652333. PubMed ID: 33912061
[No Abstract] [Full Text] [Related]
14. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
[TBL] [Abstract][Full Text] [Related]
15. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
[TBL] [Abstract][Full Text] [Related]
16. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
Cortinovis M; Gotti E; Pradini S; Gaspari F; Perico N
Transplantation; 2011 Sep; 92(5):550-6. PubMed ID: 21709602
[TBL] [Abstract][Full Text] [Related]
17. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
Kuypers DR; de Jonge H; Naesens M; de Loor H; Halewijck E; Dekens M; Vanrenterghem Y
Clin Ther; 2008 Apr; 30(4):673-83. PubMed ID: 18498916
[TBL] [Abstract][Full Text] [Related]
18. Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2008 Oct; 30(5):570-5. PubMed ID: 18758392
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus.
Enokiya T; Nishikawa K; Muraki Y; Iwamoto T; Kanda H; Sugimura Y; Okuda M
J Pharm Health Care Sci; 2017; 3():17. PubMed ID: 28652924
[TBL] [Abstract][Full Text] [Related]
20. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]